To our knowledge, this is the first study to give a comprehensive picture of the 18F-PSMA-1007 PET/CT validation for primary prostate cancer metastasis degree and oligo-metastasis status discrimination. This evidence concerns the gene FOLH1 and prostate carcinoma.